Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 52 entries
Sorted by: Best Match Show Resources per page
Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study.

Frontiers in neurology

Rostami E, Engquist H, Johnson U, Howells T, Ronne-Engström E, Nilsson P, Hillered L, Lewén A, Enblad P.
PMID: 24917850
Front Neurol. 2014 Jun 02;5:89. doi: 10.3389/fneur.2014.00089. eCollection 2014.

Cerebral ischemia is the leading cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). Although 70% of the patients show angiographic vasospasm only 30% develop symptomatic vasospasm defined as delayed cerebral ischemia (DCI). Early detection and management of...

Cite
Rostami E, Engquist H, Johnson U, et al. Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study. Front Neurol. 2014;5:89doi: 10.3389/fneur.2014.00089.
Rostami, E., Engquist, H., Johnson, U., Howells, T., Ronne-Engström, E., Nilsson, P., Hillered, L., Lewén, A., & Enblad, P. (2014). Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study. Frontiers in neurology, 589. https://doi.org/10.3389/fneur.2014.00089
Rostami, Elham, et al. "Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study." Frontiers in neurology vol. 5 (2014): 89. doi: https://doi.org/10.3389/fneur.2014.00089
Rostami E, Engquist H, Johnson U, Howells T, Ronne-Engström E, Nilsson P, Hillered L, Lewén A, Enblad P. Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study. Front Neurol. 2014 Jun 02;5:89. doi: 10.3389/fneur.2014.00089. eCollection 2014. PMID: 24917850; PMCID: PMC4041006.
Copy Download .nbib Format: NLM
[Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer].

Lakartidningen

Hillerdal G.
PMID: 10575882
Lakartidningen. 1999 Oct 27;96(43):4691.

No abstract available.

Cite
Hillerdal G. Rekommendationer utarbetade av Svenska lungcancerstudiegruppen. Kortare väntetider ett kvalitetskrav vid utredningar av lungcancer. [Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer]. Lakartidningen. 1999;96(43):4691
Hillerdal, G. (1999). Rekommendationer utarbetade av Svenska lungcancerstudiegruppen. Kortare väntetider ett kvalitetskrav vid utredningar av lungcancer. [Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer]. Lakartidningen, 96(43), 4691.
Hillerdal, G. "Rekommendationer utarbetade av Svenska lungcancerstudiegruppen. Kortare väntetider ett kvalitetskrav vid utredningar av lungcancer." [Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer]. Lakartidningen vol. 96,43 (1999): 4691.
Hillerdal G. Rekommendationer utarbetade av Svenska lungcancerstudiegruppen. Kortare väntetider ett kvalitetskrav vid utredningar av lungcancer. [Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer]. Lakartidningen. 1999 Oct 27;96(43):4691. Swedish. PMID: 10575882.
Copy Download .nbib Format: NLM
THE ALTERED PROGNOSIS IN TUBERCULOSIS.

Acta tuberculosea et pneumologica Scandinavica. Supplementum

HILLERDAL O.
PMID: 14160967
Acta Tuberc Pneumol Scand Suppl. 1964;56:SUPPL 56:96-8.

No abstract available.

Cite
HILLERDAL O. THE ALTERED PROGNOSIS IN TUBERCULOSIS. Acta Tuberc Pneumol Scand Suppl. 1964;56:SUPPL 56:96-8
HILLERDAL, O. (1964). THE ALTERED PROGNOSIS IN TUBERCULOSIS. Acta tuberculosea et pneumologica Scandinavica. Supplementum, 56SUPPL 56:96-8.
HILLERDAL, O. "THE ALTERED PROGNOSIS IN TUBERCULOSIS." Acta tuberculosea et pneumologica Scandinavica. Supplementum vol. 56 (1964): SUPPL 56:96-8.
HILLERDAL O. THE ALTERED PROGNOSIS IN TUBERCULOSIS. Acta Tuberc Pneumol Scand Suppl. 1964;56:SUPPL 56:96-8. PMID: 14160967.
Copy Download .nbib Format: NLM
Recent advances in parathyroid imaging.

Trends in endocrinology and metabolism: TEM

Turton DB, Miller DL.
PMID: 18406743
Trends Endocrinol Metab. 1996 Jul;7(5):163-8. doi: 10.1016/1043-2760(96)00044-6.

Although no existing imaging procedure is as effective as an experienced surgeon for locating abnormal parathyroid glands in patients without previous neck surgery, preoperative parathyroid localization is considered essential for patients undergoing reoperations. The need for parathyroid imaging in...

Cite
Turton DB, Miller DL. Recent advances in parathyroid imaging. Trends Endocrinol Metab. 1996;7(5):163-8doi: 10.1016/1043-2760(96)00044-6.
Turton, D. B., & Miller, D. L. (1996). Recent advances in parathyroid imaging. Trends in endocrinology and metabolism: TEM, 7(5), 163-8. https://doi.org/10.1016/1043-2760(96)00044-6
Turton, D B, and Miller, D L. "Recent advances in parathyroid imaging." Trends in endocrinology and metabolism: TEM vol. 7,5 (1996): 163-8. doi: https://doi.org/10.1016/1043-2760(96)00044-6
Turton DB, Miller DL. Recent advances in parathyroid imaging. Trends Endocrinol Metab. 1996 Jul;7(5):163-8. doi: 10.1016/1043-2760(96)00044-6. PMID: 18406743.
Copy Download .nbib Format: NLM
Psychological distress and well-being in advanced cancer: The effects of optimism and coping.

Journal of clinical psychology in medical settings

Miller DL, Manne SL, Taylor K, Keates J, Dougherty J.
PMID: 24226639
J Clin Psychol Med Settings. 1996 Jun;3(2):115-30. doi: 10.1007/BF01996132.

This study examined the relations among optimism, coping, functional status, and psychological adjustment in 75 adults diagnosed with cancer. Both the positive and the negative aspects of psychological adjustment were assessed. All participants had been diagnosed with advanced stages...

Cite
Miller DL, Manne SL, Taylor K, et al. Psychological distress and well-being in advanced cancer: The effects of optimism and coping. J Clin Psychol Med Settings. 1996;3(2):115-30doi: 10.1007/BF01996132.
Miller, D. L., Manne, S. L., Taylor, K., Keates, J., & Dougherty, J. (1996). Psychological distress and well-being in advanced cancer: The effects of optimism and coping. Journal of clinical psychology in medical settings, 3(2), 115-30. https://doi.org/10.1007/BF01996132
Miller, D L, et al. "Psychological distress and well-being in advanced cancer: The effects of optimism and coping." Journal of clinical psychology in medical settings vol. 3,2 (1996): 115-30. doi: https://doi.org/10.1007/BF01996132
Miller DL, Manne SL, Taylor K, Keates J, Dougherty J. Psychological distress and well-being in advanced cancer: The effects of optimism and coping. J Clin Psychol Med Settings. 1996 Jun;3(2):115-30. doi: 10.1007/BF01996132. PMID: 24226639.
Copy Download .nbib Format: NLM
CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage.

Journal of neurosurgery

Engquist H, Lewén A, Hillered L, Ronne-Engström E, Nilsson P, Enblad P, Rostami E.
PMID: 31923897
J Neurosurg. 2020 Jan 10;1-10. doi: 10.3171/2019.11.JNS192759. Epub 2020 Jan 10.

OBJECTIVE: Despite the multifactorial pathogenesis of delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH), augmentation of cerebral blood flow (CBF) is still considered essential in the clinical management of DCI. The aim of this prospective observational study was to...

Cite
Engquist H, Lewén A, Hillered L, et al. CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage. J Neurosurg. 2020;1-10doi: 10.3171/2019.11.JNS192759.
Engquist, H., Lewén, A., Hillered, L., Ronne-Engström, E., Nilsson, P., Enblad, P., & Rostami, E. (2020). CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage. Journal of neurosurgery, 1-10. https://doi.org/10.3171/2019.11.JNS192759
Engquist, Henrik, et al. "CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage." Journal of neurosurgery vol. (2020): 1-10. doi: https://doi.org/10.3171/2019.11.JNS192759
Engquist H, Lewén A, Hillered L, Ronne-Engström E, Nilsson P, Enblad P, Rostami E. CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage. J Neurosurg. 2020 Jan 10;1-10. doi: 10.3171/2019.11.JNS192759. Epub 2020 Jan 10. PMID: 31923897.
Copy Download .nbib Format: NLM
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

Clinical oncology (Royal College of Radiologists (Great Britain))

Earl HM, Hiller L, Dunn J, Macpherson I, Rea D, Hughes-Davies L, McAdam K, Hall P, Mansi J, Wheatley D, Abraham JE, Caldas C, Gasson S, O'Riordan E, Wilcox M, Miles D, Cameron DA, Wardley A.
PMID: 32723485
Clin Oncol (R Coll Radiol). 2021 Jan;33(1):15-19. doi: 10.1016/j.clon.2020.07.006. Epub 2020 Jul 25.

No abstract available.

Cite
Earl HM, Hiller L, Dunn J, et al. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Clin Oncol (R Coll Radiol). 2020;33(1):15-19doi: 10.1016/j.clon.2020.07.006.
Earl, H. M., Hiller, L., Dunn, J., Macpherson, I., Rea, D., Hughes-Davies, L., McAdam, K., Hall, P., Mansi, J., Wheatley, D., Abraham, J. E., Caldas, C., Gasson, S., O'Riordan, E., Wilcox, M., Miles, D., Cameron, D. A., & Wardley, A. (2021). Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Clinical oncology (Royal College of Radiologists (Great Britain)), 33(1), 15-19. https://doi.org/10.1016/j.clon.2020.07.006
Earl, H M, et al. "Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK." Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 33,1 (2021): 15-19. doi: https://doi.org/10.1016/j.clon.2020.07.006
Earl HM, Hiller L, Dunn J, Macpherson I, Rea D, Hughes-Davies L, McAdam K, Hall P, Mansi J, Wheatley D, Abraham JE, Caldas C, Gasson S, O'Riordan E, Wilcox M, Miles D, Cameron DA, Wardley A. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):15-19. doi: 10.1016/j.clon.2020.07.006. Epub 2020 Jul 25. PMID: 32723485; PMCID: PMC7382576.
Copy Download .nbib Format: NLM
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

The Lancet. Oncology

Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF.
PMID: 34902335
Lancet Oncol. 2021 Dec 10; doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 10.

BACKGROUND: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the relationship of RCB with long-term prognosis across...

Cite
Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2021;doi: 10.1016/S1470-2045(21)00589-1.
Yau, C., Osdoit, M., van der Noordaa, M., Shad, S., Wei, J., de Croze, D., Hamy, A. S., Laé, M., Reyal, F., Sonke, G. S., Steenbruggen, T. G., van Seijen, M., Wesseling, J., Martín, M., Del Monte-Millán, M., López-Tarruella, S., Boughey, J. C., Goetz, M. P., Hoskin, T., Gould, R., Valero, V., Edge, S. B., Abraham, J. E., Bartlett, J. M. S., Caldas, C., Dunn, J., Earl, H., Hayward, L., Hiller, L., Provenzano, E., Sammut, S. J., Thomas, J. S., Cameron, D., Graham, A., Hall, P., Mackintosh, L., Fan, F., Godwin, A. K., Schwensen, K., Sharma, P., DeMichele, A. M., Cole, K., Pusztai, L., Kim, M. O., van 't Veer, L. J., Esserman, L. J., & Symmans, W. F. (2021). Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. The Lancet. Oncology, . https://doi.org/10.1016/S1470-2045(21)00589-1
Yau, Christina, et al. "Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients." The Lancet. Oncology vol. (2021). doi: https://doi.org/10.1016/S1470-2045(21)00589-1
Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2021 Dec 10; doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 10. PMID: 34902335.
Copy Download .nbib Format: NLM
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

The Lancet. Oncology

Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF.
PMID: 34902335
Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11.

BACKGROUND: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the relationship of RCB with long-term prognosis across...

Cite
Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2021;23(1):149-160doi: 10.1016/S1470-2045(21)00589-1.
Yau, C., Osdoit, M., van der Noordaa, M., Shad, S., Wei, J., de Croze, D., Hamy, A. S., Laé, M., Reyal, F., Sonke, G. S., Steenbruggen, T. G., van Seijen, M., Wesseling, J., Martín, M., Del Monte-Millán, M., López-Tarruella, S., Boughey, J. C., Goetz, M. P., Hoskin, T., Gould, R., Valero, V., Edge, S. B., Abraham, J. E., Bartlett, J. M. S., Caldas, C., Dunn, J., Earl, H., Hayward, L., Hiller, L., Provenzano, E., Sammut, S. J., Thomas, J. S., Cameron, D., Graham, A., Hall, P., Mackintosh, L., Fan, F., Godwin, A. K., Schwensen, K., Sharma, P., DeMichele, A. M., Cole, K., Pusztai, L., Kim, M. O., van 't Veer, L. J., Esserman, L. J., & Symmans, W. F. (2022). Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. The Lancet. Oncology, 23(1), 149-160. https://doi.org/10.1016/S1470-2045(21)00589-1
Yau, Christina, et al. "Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients." The Lancet. Oncology vol. 23,1 (2022): 149-160. doi: https://doi.org/10.1016/S1470-2045(21)00589-1
Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11. PMID: 34902335.
Copy Download .nbib Format: NLM
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

The Lancet. Oncology

Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF.
PMID: 34902335
Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11.

BACKGROUND: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the relationship of RCB with long-term prognosis across...

Cite
Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2021;23(1):149-160doi: 10.1016/S1470-2045(21)00589-1.
Yau, C., Osdoit, M., van der Noordaa, M., Shad, S., Wei, J., de Croze, D., Hamy, A. S., Laé, M., Reyal, F., Sonke, G. S., Steenbruggen, T. G., van Seijen, M., Wesseling, J., Martín, M., Del Monte-Millán, M., López-Tarruella, S., Boughey, J. C., Goetz, M. P., Hoskin, T., Gould, R., Valero, V., Edge, S. B., Abraham, J. E., Bartlett, J. M. S., Caldas, C., Dunn, J., Earl, H., Hayward, L., Hiller, L., Provenzano, E., Sammut, S. J., Thomas, J. S., Cameron, D., Graham, A., Hall, P., Mackintosh, L., Fan, F., Godwin, A. K., Schwensen, K., Sharma, P., DeMichele, A. M., Cole, K., Pusztai, L., Kim, M. O., van 't Veer, L. J., Esserman, L. J., & Symmans, W. F. (2022). Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. The Lancet. Oncology, 23(1), 149-160. https://doi.org/10.1016/S1470-2045(21)00589-1
Yau, Christina, et al. "Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients." The Lancet. Oncology vol. 23,1 (2022): 149-160. doi: https://doi.org/10.1016/S1470-2045(21)00589-1
Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11. PMID: 34902335.
Copy Download .nbib Format: NLM
"Symptoms associated with environmental factors" (SAEF) - Towards a paradigm shift regarding "idiopathic environmental intolerance" and related phenomena.

Journal of psychosomatic research

Haanes JV, Nordin S, Hillert L, Witthöft M, van Kamp I, van Thriel C, Van den Bergh O.
PMID: 32058864
J Psychosom Res. 2020 Feb 05;131:109955. doi: 10.1016/j.jpsychores.2020.109955. Epub 2020 Feb 05.

Health conditions characterized by symptoms associated with chemical, physical and biological environmental factors unrelated to objectifiable pathophysiological mechanisms are often labelled by the general term "idiopathic environmental intolerances". More specific, exposure-related terms are also used, e.g. "multiple chemical sensitivities",...

Cite
Haanes JV, Nordin S, Hillert L, et al. "Symptoms associated with environmental factors" (SAEF) - Towards a paradigm shift regarding "idiopathic environmental intolerance" and related phenomena. J Psychosom Res. 2020;131:109955doi: 10.1016/j.jpsychores.2020.109955.
Haanes, J. V., Nordin, S., Hillert, L., Witthöft, M., van Kamp, I., van Thriel, C., & Van den Bergh, O. (2020). "Symptoms associated with environmental factors" (SAEF) - Towards a paradigm shift regarding "idiopathic environmental intolerance" and related phenomena. Journal of psychosomatic research, 131109955. https://doi.org/10.1016/j.jpsychores.2020.109955
Haanes, Jan Vilis, et al. ""Symptoms associated with environmental factors" (SAEF) - Towards a paradigm shift regarding "idiopathic environmental intolerance" and related phenomena." Journal of psychosomatic research vol. 131 (2020): 109955. doi: https://doi.org/10.1016/j.jpsychores.2020.109955
Haanes JV, Nordin S, Hillert L, Witthöft M, van Kamp I, van Thriel C, Van den Bergh O. "Symptoms associated with environmental factors" (SAEF) - Towards a paradigm shift regarding "idiopathic environmental intolerance" and related phenomena. J Psychosom Res. 2020 Feb 05;131:109955. doi: 10.1016/j.jpsychores.2020.109955. Epub 2020 Feb 05. PMID: 32058864.
Copy Download .nbib Format: NLM
Research in Music with Electronics.

Science (New York, N.Y.)

Hiller L, Beauchamp J.
PMID: 17787268
Science. 1965 Oct 08;150(3693):161-9. doi: 10.1126/science.150.3693.161.

No abstract available.

Cite
Hiller L, Beauchamp J. Research in Music with Electronics. Science. 1965;150(3693):161-9doi: 10.1126/science.150.3693.161.
Hiller, L., & Beauchamp, J. (1965). Research in Music with Electronics. Science (New York, N.Y.), 150(3693), 161-9. https://doi.org/10.1126/science.150.3693.161
Hiller, L, and Beauchamp, J. "Research in Music with Electronics." Science (New York, N.Y.) vol. 150,3693 (1965): 161-9. doi: https://doi.org/10.1126/science.150.3693.161
Hiller L, Beauchamp J. Research in Music with Electronics. Science. 1965 Oct 08;150(3693):161-9. doi: 10.1126/science.150.3693.161. PMID: 17787268.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 52 entries